Catheter Precision, Inc. Introduces LockeT Suturing Device at International Left Atrial Symposium

Catheter Precision, Inc., a US company specializing in innovative electrophysiology-focused medical devices, announced its participation in the International Symposium on the Left Atrial Appendage (ISLAA), held in New York. This annual symposium, scheduled for March 1-2, 2024, represents a major event for cardiovascular health professionals. Catheter Precision CEO David Jenkins says LockeT received an excellent reception at the Western Atrial Fibrillation Symposium, highlighting the importance of these meetings in disseminating and sharing medical innovations.

The LockeT is a suturing device designed to facilitate hemostasis after percutaneous venipunctures, registered with the FDA as a Class 1 device. ISLAA highlights therapeutic advances, including cardiac devices for exclusion of the left atrial appendage, and thus attracts a wider audience of health professionals. This year, the focus will be on the anatomy, physiology and pathological aspects of the left atrial appendage (LAA), providing an enriching platform for exchange for participants.